Journal article
ATNT-12PHASE I, TWO-STAGE, OPEN-LABEL, DOSE-ESCALATION STUDY OF BUPARLISIB (BKM120) IN COMBINATION WITH ADJUVANT TEMOZOLOMIDE (TMZ) AND WITH CONCOMITANT RADIATION THERAPY (RT) AND TMZ IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
Authors
Rodon J; Rosenthal M; Mason W; Segura PP; Beck JT; Hirte H; DeGroot JF; Trandafir L; Pognan N; Yang L
Journal
Neuro-Oncology, Vol. 17, No. suppl_5, pp. v12–v13
Publisher
Oxford University Press (OUP)
Publication Date
November 1, 2015
DOI
10.1093/neuonc/nov205.12
ISSN
1522-8517